# CARBIDOPA, LEVODOPA AND ENTACAPONE
> **ANDA213212** · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2022-01-25
## Drug
- **FDA Application Number:** ANDA213212
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CARBIDOPA, LEVODOPA AND ENTACAPONE
- **Generic name:** CARBIDOPA, LEVODOPA AND ENTACAPONE
- **Active ingredients:** CARBIDOPA; ENTACAPONE; LEVODOPA
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RISING
- **Manufacturer:** Rising Pharma Holdings, Inc.
- **First approval:** 2022-01-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213212)
---
*AI Analytics · CC0 1.0*